Search This Blog

Friday, March 13, 2026

Acurx narrows FY25 net loss. launches recurrent CDI program amid Phase III funding overhang

 

Acurx narrows FY25 net loss to $8.0M and launches recurrent CDI program amid Phase III funding overhang

  • Non-GAAP EPS $-0.73 improved 77% YoY on zero revenue, beating quarterly revenue estimates.
  • No revenue; FY25 net loss narrowed to $8.0M from $14.1M on lower expenses.
  • Cash ended 2025 at $7.6M versus $3.7M prior year; equity line remains available.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)